In this article
High-Intensity Focused Ultrasound (HIFU) Technology and Precision
March 2022: HIFU (High Intensity Focused Ultrasound) is a cutting-edge therapy that uses focused, high-energy ultrasound waves to heat and kill cancerous parts of the prostate gland. The target tissue is heated to 880 to 980 degrees Celsius after each 3-second burst of the HIFU beam. The temperature in some locations approaches 1000 degrees, causing the water in the tissue to boil! The prostate cells in the treated area are promptly destroyed. Each 3-second burst destroys tissue the size of a grain of rice while causing no harm to neighboring cells. Because each treated area is so small, it takes a lot of skill and precision to properly treat a prostate with HIFU and achieve the best outcomes.
Because of the HIFU beam’s small size and precision, treated individuals have significantly reduced urine incontinence and erectile dysfunction. These are the two most dreaded, life-altering adverse effects that patients fear, and which lead to many men avoiding prostate cancer treatment.
The Sonablate® 500 HIFU device’s sophisticated computer software includes an ultrasound imaging technology that targets prostate cells without injuring surrounding tissue. As a result, as compared to robotic surgery, HIFU has a far higher cure rate and generates significantly less incontinence.
Doppler is another aspect of the sophisticated HIFU ultrasound technology. This allows doctor to hear blood flow near the nerves that control erections outside the prostate. Damage to these vital neurons and blood vessels can be reduced or avoided by programming the blood vessel locations into the therapy software computer. Erectile dysfunction (ED) is unlikely as a result of this.
Benefits of HIFU
- Absolutely no incisions are needed.
- HIFU is an outpatient procedure done in a surgical center.
- No hospital stay required.
- You’ll have a much shorter recovery compared to radical surgery.
- The treatment takes a few hours as compared to weeks for most radiation treatments.
- Most normal activities can be resumed in a few days.
- There is minimal to no pain.
- HIFU causes a decreased risk of damage to surrounding structures.
- HIFU has the lowest rate of urinary incontinence.
- HIFU has the lowest rate of erectile dysfunction.
Who are the good candidates of HIFU?
You may be a good candidate for HIFU if:
- You have early stage, a localized prostate cancer that has not spread or metastasized outside the prostate.
- You have recurrent prostate cancer after radiation therapy of any type, or if other treatment options pose a high risk of complications.
- You want to avoid the side effects and potential complications of radical surgery or radiation.
How is HIFU performed?
Under general, spinal, or epidural anaesthesia, HIFU is conducted. Depending on the size and shape of your prostate, the treatment can take anywhere from 2 to 4 hours. You will be discharged home after a brief stay in the recovery area, where you will be followed by the surgery center’s nursing staff.
After HIFU
The heat created during an HIFU therapy causes all prostates to enlarge. Urination is impossible as a result of this. A thin tube (catheter) is inserted into your bladder through a 3/16″ skin hole just above your pubic bone right before the HIFU operation begins. The tube will drain pee from your bladder into a tiny bag that straps onto your leg until the swelling goes down and you can urinate normally. It’s hidden under your pants, so no one but you knows it’s there. It does not go into the urethra, unlike catheters used after severe surgery, therefore it is significantly more pleasant and has a far lower risk of infection.
Patients may pass small amounts of blood, old prostate tissue, or mucus-like substance in their urine during the next few weeks. Most individuals urinate better than they did before the HIFU therapy once all of the prostate tissue has been removed.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Related Articles

About Susan Hau
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy. Hau's expertise lies in cancer cell biolo…
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.


